Lamivudine treatment for acute hepatitis B after liver transplantation

Journal of Hepatology

Volumn 29, Issue 6, 1998, Pages 985-989

  Andreone, Pietro ^d   Caraceni, Paolo ^d   Grazi, Gian Luca ^d   Belli, Luca ^a   Milandri, Gian Luigi ^b   Ercolani, Giorgio ^d   Jovine, Elio ^d   D'Errico, Antonia ^d   Dal Monte, Pier Roberto ^b   Ideo, Gaetano ^a   Forti, Domenico ^a   Mazziotti, Alighieri ^d   Cavallari, Antonino ^d   Bernardi, Mauro ^c  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b Serv di Gastroenterologia Osp B   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d NONE

Author keywords

Lamivudine; Liver transplantation; Recurrent or de novo acute hepatitis B

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; STEROID; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RECURRENT INFECTION; VIRUS REPLICATION;

EID: 0032404086     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80127-X     Document Type: Article

References (12)

1. 1. Samuel D, Muller R, Alexander G, Fassat, L. Ducot B, Benhamou JP, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329: 1842-7.
2. 2. Nevens F, Main J, Honkoop P, Tyrrell DL, Barber J, Sullivan MT, et al. Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study. Gastroenterology 1997: 113: 1258-63.
3. 3. Perrillo B, Rakela J, Martin P, Levy G, Schippe E, Wright T, et al. Long-term lamivudine therapy of patients with recurrent hepatitis B post liver transplantation [abstract]. Hepatology 1997; 26: 177A.
4. 4. Al Faraidy K, Yoshida EM, Davis JE, Vartanian RK, Anderson FN, Steinbrecher UP. Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine. Transplantation 1997; 64: 926-8.
5. 5. Ben-Ari Z, Shmueli D, Mor E, Shapira Z, Tur-Kaspa R. Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation. Transplantation 1997; 63: 393-6.
6. 6. Grazi GL, Mazziotti AL, Sama C, Jovine E, Stefanini F, Poladi R, et al. Liver transplantation in HBsAg-positive HBV-DNA negative cirrhotics: immunoprophylaxis and long-term outcome. Liver Transpl Surg 1996; 2: 418-25.
7. 7. Bonino F, Rosina F, Rizzetto M, Rizzi R, Chiaberge E, Tardanico R, et al. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology 1986; 90: 1268-73.
8. 8. Angus PW, Locarnini SA, McCaughan GW, Jones RW, McMillan JS, Bowden DS. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. Hepatology 1995; 21: 14-8.
9. 9. Perrillo RB, Shiff ER, Davis GL, Bodenheimer HC Jr, Lindsay K, Payne J, et al. A randomized, control trial of interferon alpha-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990: 323: 295-301.
10. 10. Bain VG, Kneteman NM, Ma MM, Gutfreund K, Shapiro JA, Fisher K, et al. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation 1996; 62: 1456-62.
11. 11. Tipples GA, Ma MM, Fisher KP, Bain VG, Kneteman NM, Tyrrell DLJ. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996; 24: 714-7.
12. 12. Shields PL, Ling R, Harrison T, Boxall E, Elias E, Mitimer DJ. Management and outcome of lamivudine-resistant hepatitis B virus infection after liver transplantation [abstract]. Hepatology 1997; 26: 260A.